PIRS News and Press, Pieris Pharmaceuticals Inc. From 08/01/19

BOSTON, MA / ACCESSWIRE / August 1, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS ) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, to...

Cellectar Biosciences (NASDAQ: CLRB ) initiated with Buy rating and $6 (180% upside) price target at Brookline Capital. Shares up  8%  premarket. More news on: Cellectar Biosciences, Inc., Heat Biologics, Inc., Progenics Pharmaceuticals, Inc., Healthcare stocks news, Stocks on th...

Gainers:  NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...

Pieris Pharmaceuticals ( PIRS +14.5% ) is up on a 4x surge in volume in apparent response to a bullish note from William Blair's Matt Phipps who says its inhaled PRS-060 should be a winner in patients with severe asthma. More news on: Pieris Pharmaceuticals, Inc., Healthcare stocks news,...

Medley Management (NYSE: MDLY ) +35%  as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...

BOSTON, MA / ACCESSWIRE / July 25, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for respiratory diseases, cancer and other indications, today announced ...

BOSTON, MA / ACCESSWIRE / May 30, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory, cancer and other diseases, announced today that Stephen ...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) stayed in the green again last week, rising from 3,234.74 points on Monday (May 20) to 3,280.05 points as of 1:02 p.m. EDT on Friday (May 24).  In terms of biotech and pharma stocks, last week shares of Sesen Bio (NASDAQ: SESN ) jumped ...

Gainers:  Avianca Holdings (NYSE: AVH ) +29% . Outlook Therapeutics (NASDAQ: OTLK ) +28% . Hibbett Sports (NASDAQ: HIBB ) +21% . Total System Services (NYSE: TSS ) +16% . Cavco Industries (NASDAQ: CVCO ) +16% . Biocept (NASDAQ: BIOC ) +13% . DASAN Zhone Solutions (NASDAQ: DZSI )...

BOSTON, MA / ACCESSWIRE / May 22, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced t...